Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Hyperthermia 9 Prostatic Neoplasms 4 Uterine Cervical Neoplasms 3 Ovarian Neoplasms 3 Sarcoma 2 Neoplasms 2 Melanoma 2 Lung Neoplasms 2 Head and Neck Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Salivary Gland Adenoma, Pleomorphic 1 Recurrence 1 Rectal Neoplasms 1 Prehypertension 1 Prediabetic State 1 Polycystic Ovary Syndrome 1 Pelvic Pain 1 Obesity 1 Neoplasms, Radiation-Induced 1 Neoplasm Metastasis 1 Metabolic Syndrome 1 Locally Advanced Rectal Cancer 1 Liver Neoplasms 1 Kidney Neoplasms 1 Cholangiocarcinoma 1 Agnosia 1 Acute Pain 1

Interventions

Transcutaneous Electric Nerve Stimulation 1 Tea 1 Ropivacaine 1 Oxycodone 1 Lidocaine 1 Ketamine 1 Ibuprofen 1 Gabapentin 1 Ethyl Chloride 1 Epinephrine 1 Duloxetine Hydrochloride 1 Diathermy 1 Dexmedetomidine 1 Cryotherapy 1 Control Groups 1 Bupivacaine 1 Anesthesia, General 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Acute Pain × Diathermy × Clear all

NCT04778631 2025-11-20

PERISAFE

Assistance Publique - Hôpitaux de Paris

Phase NA Completed

Hyperthermia, Agnosia, Neoplasm Metastasis, Pelvic Pain, Acute Pain

Data powered by HemOnc (CC BY 4.0) Colophon ⚡